Media In The News You are here: Home / Investors / In The News Media Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival Tocagen wins a BTD for brain cancer drug Brain cancer treatment shows promise in early trial Possible brain cancer breakthrough at UCSD Immunotherapy offers hope to brain tumor patients New treatment extends life of brain cancer patients Dr. Max Gomez of CBS New York speaks with patient Donna Hope for brain cancer patients Interview with patient Greg and Dr. Tom Mikkelsen about the Toca 5 trial Survival time increases for those with deadly brain cancer: study Viral/chemotherapy combo fights brain cancer Tumor-killing virus nearly doubles survival time of brain cancer patients Virus helps unmask anticancer drug to attack brain tumors Tocagen touts two-step cancer vaccine RiboMed biotechnologies, Tocagen collaborate on cancer prognostics Hope amid dire brain tumor diagnosis Drug combination targets brain cancer Tocagen featured on NBC news Tocagen featured on CBS news NBC affiliate features Cleveland Clinic patient in Tocagen’s investigational trial for brain cancer CBS news features Tocagen’s clinical trial for brain cancer at JFK
